🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and Rare Diseases ── 2026-11-20

Cyanotype of a lab bench: dots on a slide split into two groups, and a string bridge stops short of a blank card, meaning candidates await validation.
What this means, as an image (AI-generated, GPT Image): Read AI-derived subgroups and candidates as leads for the next validation step, not as grounds for treatment decisions.Download image (PNG, 2000×800)
2 papers in this issue. Lead: Deciphering mitochondrial dysfunction and circadian rhythm-related pathogenic patterns for the pathogenesis of Kawasaki Disease and corresponding nursing therapeutic enrichment: Evidence from machine learning-driven multi-omics and clinical validation.

New papers on rare diseases (other than neurological and cancer) and AI, collected from journal feeds, PubMed (searched across all journals) and OpenAlex (a public index used instead of Google Scholar), judged by Jev (an AI that makes language judgements): original research, AI central, which of 8 disease groups, treatment or trials, and then ranked by importance up to a daily limit. Journals are not filtered by impact factor; each paper shows its journal's IF-equivalent (OpenAlex two-year mean citedness) and the date of that value. Each entry shows the full original abstract.

Read by disease: Platforms(1) · Inborn errors of metabolism(0) · Genetic syndromes(0) · Rare blood disorders(0) · Immune and connective tissue(0) · Heart and lung(1) · Kidney, liver and gut(0) · Skin and bone(0)

Rare-disease diagnosis and drug discovery platforms and AI

See all 1 Platforms papers →

Inborn errors of metabolism: treatment, trials and AI

No new qualifying paper for this issue.

Genetic syndromes and paediatric rare diseases: treatment, trials and AI

No new qualifying paper for this issue.

Rare blood disorders: treatment, trials and AI

No new qualifying paper for this issue.

Autoinflammatory, immunodeficiency and rare connective-tissue diseases: treatment, trials and AI

No new qualifying paper for this issue.

Rare cardiovascular and respiratory diseases: treatment, trials and AI

See all 1 Heart and lung papers →

Rare kidney, liver and gastrointestinal diseases: treatment, trials and AI

No new qualifying paper for this issue.

Rare skin and bone diseases: treatment, trials and AI

No new qualifying paper for this issue.

How papers are chosen: (1) collected from journal feeds, PubMed (all journals) and OpenAlex; (2) editorials, corrections and items without field/AI terms are removed; (3) Jev judges four points (original research ≥ 0.6, AI ≥ 0.6, one of 8 disease groups, treatment/trials ≥ 0.5 for disease groups); (4) ranked by Jev importance up to a daily limit (two per group); (5) the IF-equivalent is shown only when Jev confirms the journal match. Papers Jev cannot judge are not listed.